← Back to Dashboard

Resveratrol

Multiple

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O
LUKBXSAWLPMMSZ-OWOJBTEDSA-N

Clinical Development by Virus12

Influenza A virus
FLUAV
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Rotavirus
RoV
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human gammaherpesvirus 4
EBV
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human orthopneumovirus
RSV
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Zika virus
ZIKV
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human betaherpesvirus 5
CMV
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human alphaherpesvirus 1
HSV-1
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human alphaherpesvirus 2
HSV-2
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Middle East respiratory syndrome-related coronavirus
MERS-CoV
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Severe acute respiratory syndrome-related coronavirus
SARS-CoV-2
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Enterovirus A
EV-A71
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
African swine fever virus
ASFV
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved